And Dr Robert Murphy, he was appointed by Biotron last October to head up the Scientific Advisory Board for BIT225 and clinical development.
Dr Murphy is a professor on infectious disease at Northwestern University’s Feinberg School of Medicine.
He is also the Executive Director of The Institute for Global Health.
FYI, he is on Chicago's WGN9 TV answering questions for 5 or 6 minutes every morning regarding Covid-19 (worth a look)
Good to see his name on this publication, he is very knowledgable (obviously) and as an Executive Director of The Institute of Global Health, I'm sure he has some great contacts, now all he has to do is use them!
Major Article - BIT225, in combination with 3-drug antiretroviral therapy, page-4
-
- There are more pages in this discussion • 218 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.003(9.09%) |
Mkt cap ! $27.06M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.4¢ | 3.0¢ | $32.26K | 1.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 720804 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |